| Scrip code | 511742 |
|---|---|
| NSE Symbol | UGROCAP |
| MSEI Symbol | NOTLISTED |
| ISIN | INE583D01011 |
| Name of company | Ugro Capital Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 05-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 16-10-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Business of lending and investing and primarily deals in financing SME and MSME Sector |
| Start date and time of board meeting | 05-11-2026 16:15:00 |
| End date and time of board meeting | 05-11-2026 18:15:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | |||
| (i) | Interest Income | 38,547.55 | 74,848.50 |
| (ii) | Dividend Income | 0.00 | 0.00 |
| (iii) | Rental Income | 0.00 | 0.00 |
| (iv) | Fees and commission Income | 4,114.38 | 8,902.83 |
| (v) | Net gain on fair value changes | 861.89 | 1,980.25 |
| (vi) | Net gain on derecognition of financial instruments under amortised cost category | 10,907.66 | 18,394.32 |
| (vii) | Sale of products (including Excise Duty) | 0.00 | 0.00 |
| (viii) | Sale of services | 0.00 | 0.00 |
| (ix) | Other revenue from operations | ||
| Total other revenue from operations | |||
| Total Revenue From Operations | 54,431.48 | 1,04,125.90 | |
| Other income | 3,404.50 | 7,173.09 | |
| Total income | 57,835.98 | 1,11,298.99 | |
| 2 | Expenses | ||
| Cost of materials consumed | 0.00 | 0.00 | |
| Purchases of stock-in-trade | 0.00 | 0.00 | |
| Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 | |
| Employee benefit expense | 4,363.57 | 9,146.69 | |
| Finance costs | 29,597.29 | 58,494.49 | |
| Depreciation, depletion and amortisation expense | 1,585.50 | 2,920.71 | |
| Fees and commission expense | 0.00 | 0.00 | |
| Net loss on fair value changes | 594.11 | 867.77 | |
| Net loss on derecognition of financial instruments under amortised cost category | 0.00 | 0.00 | |
| Impairment on financial instruments | 8,688.38 | 15,249.09 | |
| (f) | Other expenses | ||
| 1 | Other expenses | 6,181.68 | 11,641.07 |
| Total other expenses | 6,181.68 | 11,641.07 | |
| Total expenses | 51,010.53 | 98,319.82 | |
| 3 | Total profit before exceptional items and tax | 6,825.45 | 12,979.17 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 6,825.45 | 12,979.17 |
| 7 | Tax expense | ||
| 8 | Current tax | 1,006.72 | 1,439.14 |
| 9 | Deferred tax | 744.58 | (321.01) |
| 10 | Total tax expenses | 1,751.30 | 1,118.13 |
| 11 | Net Profit Loss for the period from continuing operations | 5,074.15 | 11,861.04 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 17 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 14 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 15 | Total profit (loss) for period | 5,074.15 | 11,861.04 |
| 16 | Other comprehensive income net of taxes | 102.58 | 127.17 |
| 17 | Total Comprehensive Income for the period | 5,176.73 | 11,988.21 |
| 18 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 0.00 | 0.00 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 19 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 0.00 | 0.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 20 | Details of equity share capital | ||
| Paid-up equity share capital | 15,281.56 | 15,281.56 | |
| Face value of equity share capital | 10 | 10 | |
| 21 | Reserves excluding revaluation reserve | ||
| 22 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings per share from continuing operations | 3.32 | 7.76 | |
| Diluted earnings per share from continuing operations | 3.32 | 7.75 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings per share from discontinued operations | 0 | 0 | |
| Diluted earnings per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings per share | 3.32 | 7.76 | |
| Diluted earnings per share | 3.32 | 7.75 | |
| 23 | Debt equity ratio | ||
| 24 | Debt service coverage ratio | ||
| 25 | Interest service coverage ratio | ||
| 26 | Disclosure of notes on financial results | ||
| 23 | Debt equity ratio | |
|---|---|---|
| 24 | Debt service coverage ratio | |
| 25 | Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| A | Date of start of reporting period | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated |
| Statement of cash flows | ||
| Cash flows from used in operating activities | ||
| Profit before tax | 12,979.17 | |
| Adjustments for reconcile profit (loss) | ||
| Adjustments for finance costs | 51,891.35 | |
| Adjustments for decrease (increase) in inventories | 0.00 | |
| Adjustments for decrease (increase) in trade receivables, current | 0.00 | |
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |
| Adjustments for decrease (increase) in other current assets | (1,108.87) | |
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |
| Adjustments for other financial assets, non-current | 0.00 | |
| Adjustments for other financial assets, current | (47,871.84) | |
| Adjustments for other bank balances | 0.00 | |
| Adjustments for increase (decrease) in trade payables, current | (4,287.36) | |
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |
| Adjustments for increase (decrease) in other current liabilities | (205.78) | |
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |
| Adjustments for depreciation and amortisation expense | 2,920.71 | |
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 15,249.09 | |
| Adjustments for provisions, current | (3,870.97) | |
| Adjustments for provisions, non-current | 0.00 | |
| Adjustments for other financial liabilities, current | 7,103.80 | |
| Adjustments for other financial liabilities, non-current | 0.00 | |
| Adjustments for unrealised foreign exchange losses gains | 0.00 | |
| Adjustments for dividend income | 0.00 | |
| Adjustments for interest income | 72,263.47 | |
| Adjustments for share-based payments | 298.87 | |
| Adjustments for fair value losses (gains) | 867.77 | |
| Adjustments for undistributed profits of associates | 0.00 | |
| Other adjustments for which cash effects are investing or financing cash flow | (5.79) | |
| Other adjustments to reconcile profit (loss) | 0.00 | |
| Other adjustments for non-cash items | (20,374.58) | |
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |
| Total adjustments for reconcile profit (loss) | (71,657.07) | |
| Net cash flows from (used in) operations | (58,677.90) | |
| Dividends received | 0.00 | |
| Interest paid | 50,980.55 | |
| Interest received | 74,832.66 | |
| Income taxes paid (refund) | 1,332.38 | |
| Other inflows (outflows) of cash | 0.00 | |
| Net cash flows from (used in) operating activities | (36,158.17) | |
| Cash flows from used in investing activities | ||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |
| Other cash receipts from sales of interests in joint ventures | 0.00 | |
| Other cash payments to acquire interests in joint ventures | 0.00 | |
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |
| Proceeds from sales of property, plant and equipment | 0.00 | |
| Purchase of property, plant and equipment | 32.83 | |
| Proceeds from sales of investment property | 0.00 | |
| Purchase of investment property | 0.00 | |
| Proceeds from sales of intangible assets | 0.00 | |
| Purchase of intangible assets | 5,918.83 | |
| Proceeds from sales of intangible assets under development | 0.00 | |
| Purchase of intangible assets under development | 0.00 | |
| Proceeds from sales of goodwill | 0.00 | |
| Purchase of goodwill | 0.00 | |
| Proceeds from biological assets other than bearer plants | 0.00 | |
| Purchase of biological assets other than bearer plants | 0.00 | |
| Proceeds from government grants | 0.00 | |
| Proceeds from sales of other long-term assets | 0.00 | |
| Purchase of other long-term assets | 0.00 | |
| Cash advances and loans made to other parties | 0.00 | |
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Dividends received | 0.00 | |
| Interest received | 217.50 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | (13,379.52) | |
| Net cash flows from (used in) investing activities | (19,113.68) | |
| Cash flows from used in financing activities | ||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |
| Payments from changes in ownership interests in subsidiaries | 0.00 | |
| Proceeds from issuing shares | 0.00 | |
| Proceeds from issuing other equity instruments | 0.00 | |
| Payments to acquire or redeem entity's shares | 0.00 | |
| Payments of other equity instruments | 0.00 | |
| Proceeds from exercise of stock options | 0.00 | |
| Proceeds from issuing debentures notes bonds etc | 0.00 | |
| Proceeds from borrowings | 3,15,793.76 | |
| Repayments of borrowings | 2,97,563.37 | |
| Payments of lease liabilities | 1,355.21 | |
| Dividends paid | 0.00 | |
| Interest paid | 0.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | 0.00 | |
| Net cash flows from (used in) financing activities | 16,875.18 | |
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (38,396.67) | |
| Effect of exchange rate changes on cash and cash equivalents | ||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |
| Net increase (decrease) in cash and cash equivalents | (38,396.67) | |
| Cash and cash equivalents cash flow statement at beginning of period | 1,37,755.43 | |
| Cash and cash equivalents cash flow statement at end of period | 99,358.76 | |
| Particulars | Year ended (dd-mm-yyyy) | ||
|---|---|---|---|
| Date of start of reporting period | 01-04-2026 | ||
| Date of end of reporting period | 30-09-2026 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Consolidated | ||
| Assets | |||
| 1 | Finanical Asset | ||
| Cash and cash equivalents | 99,358.76 | ||
| Bank Balance other than (a) above | 48,621.02 | ||
| Derivative financial instruments | 9,563.78 | ||
| Receivables | |||
| (I) Trade Receivables | 0.00 | ||
| (II) Other Receivables | 0.00 | ||
| Loans | 10,77,990.23 | ||
| Investments | 84,192.75 | ||
| Other Financial assets | |||
| 1 | Other financial assets | 12,804.14 | |
| Total of Other Financial assets | 12,804.14 | ||
| Total Financial Assets | 13,32,530.68 | ||
| 2 | Non Financial Asset | ||
| Inventories | 0.00 | ||
| Current tax assets (Net) | 617.32 | ||
| Deferred tax Assets (Net) | 0.00 | ||
| Investment Property | 0.00 | ||
| Biological assets other than bearer plants | 0.00 | ||
| Property, Plant and Equipment | 34,804.87 | ||
| Capital work-in-progress | 0.00 | ||
| Intangible assets under development | 3,190.29 | ||
| Goodwill | 34,163.29 | ||
| Other Intangible assets | 9,961.64 | ||
| Other non-financial assets | |||
| 1 | Other non-financial assets | 19,287.86 | |
| Total of Other non-financial assets | 19,287.86 | ||
| Total Non Financial Assets | 1,02,025.27 | ||
| Total assets | 14,34,555.95 | ||
| Equity and liabilities | |||
| 1 | Equity | ||
| Equity attributable to owners of parent | |||
| Equity share capital | 15,281.56 | ||
| Other equity | 2,87,607.43 | ||
| Total equity attributable to owners of parent | 3,02,888.99 | ||
| Non controlling interest | |||
| Total equity | 3,02,888.99 | ||
| 2 | Liabilities | ||
| 2.1 | Financial Liabilities | ||
| (a) | Derivative financial instruments | 178.87 | |
| (b) | Payables | 0.00 | |
| (I)Trade Payables | |||
| (i) total outstanding dues of micro enterprises and small enterprises | 10.25 | ||
| (ii) total outstanding dues of creditors other than micro enterprises and small enterprises | 1,265.64 | ||
| II) Other Payables | |||
| (i) total outstanding dues of micro enterprises and small enterprises | 0.00 | ||
| (ii) total outstanding dues of creditors other than micro enterprises and small enterprises | 289.84 | ||
| (C ) | Debt Securities | 3,90,935.51 | |
| (d) | Borrowings (Other than Debt Securities) | 6,60,073.51 | |
| (e) | Deposits | 0.00 | |
| (f) | Subordinated Liabilities | 46,305.45 | |
| Other financial liabilities | |||
| 1 | Other financial liabilities | 17,513.86 | |
| Total of Other financial liabilities | 17,513.86 | ||
| Total Financial Liabilities | 11,16,572.93 | ||
| 2.2 | Non-Financial Liabilities | ||
| (a) | Current tax liabilities (Net) | 1,453.47 | |
| (b) | Provisions | 7,722.91 | |
| (C ) | Deferred tax liabilities (Net) | 4,551.75 | |
| Other non-financial liabilities | |||
| 1 | Other non-financial liabilities | 1,365.90 | |
| Total of Other non-financial liabilities | 1,365.90 | ||
| Total Non Financial Liabilities | 15,094.03 | ||
| Total liabilities | 11,31,666.96 | ||
| Total equity and liabilites | 14,34,555.95 | ||
| Disclosure of notes on assets and liabilities | |||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | Consolidated | |
| 1 | Segment Revenue (Income) | ||
| (net sale/income from each segment should be disclosed) | |||
| Total Segment Revenue | |||
| Less: Inter segment revenue | |||
| Revenue from operations | |||
| 2 | Segment Result | ||
| Profit (+) / Loss (-) before tax and interest from each segment | |||
| Total Profit before tax | |||
| i. Finance cost | |||
| ii. Other Unallocable Expenditure net off Unallocable income | |||
| Profit before tax | |||
| 3 | (Segment Asset - Segment Liabilities) | ||
| Segment Asset | |||
| Total Segment Asset | |||
| Un-allocable Assets | |||
| Net Segment Asset | |||
| 4 | Segment Liabilities | ||
| Segment Liabilities | |||
| Total Segment Liabilities | |||
| Un-allocable Liabilities | |||
| Net Segment Liabilities | |||
| Disclosure of notes on segments | |||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurements of the defined benefit plans | -215000 | 11490000 |
| Total Amount of items that will not be reclassified to profit and loss | -215000 | 11490000 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (3.02) | 28.92 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | The effective portion of gains and (loss) on hedging instrument in a cash flow hedge | 13592000 | 5504000 |
| Total Amount of items that will be reclassified to profit and loss | 13592000 | 5504000 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 34.21 | 13.85 |
| 5 | Total Other comprehensive income | 102.58 | 127.17 |